A randomised trial of adjuvant 5-fluorouracil, leucovorin and radiotherapy in colorectal adenocarcinoma
Not Applicable
Completed
- Conditions
- CancerColon, Rectal cancer1. Malignant neoplasm of colon2. Malignant neoplasm of rectum
- Registration Number
- ISRCTN88796215
- Lead Sponsor
- Wyeth-Lederle Ltd (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 0
Inclusion Criteria
1. Aged 18 to 80 years
2. World Health Organisation (WHO) performance status zero to two
3. Histological proof of colorectal adenocarcinoma
4. The entire colorectum must be visualised pre- or postoperatively to exclude synchronous carcinoma
5. Potentially curative surgery
6. Adjuvant treatment to be initiated within six weeks of surgery
7. Adequate bone marrow, renal and hepatic function
Exclusion Criteria
No previous malignancy except carcinoma in situ of cervix or basal cell carcinoma of skin
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ot provided at time of registration
- Secondary Outcome Measures
Name Time Method ot provided at time of registration